Catalent


	This webcast will provide a solid understanding of the Over the Counter (OTC) market performance before the novel coronavirus outbreak occurred, what the CARES Act is and how OTC Monograph Reform affects the industry, and what the innovation trends and opportunities are looking forward.  This will ensure that key lessons and opportunities are remembered amid extraordinary consumer buying trends driven by the outbreak, providing a solid baseline for future planning.

Nicholas Hall, Chairman & CEO, The Nicholas Hall Group of Companies

	John Punzi, Ph.D., Senior Director Quality Assurance & Technical Affairs, Consumer Healthcare Products Association (CHPA)

	Cornell Stamoran, Ph.D., Vice President Strategy & Government Affairs, Catalent

	Mark Gardella, R..Ph., Vice President Product Development, Consumer Health, Catalent

Tuesday, May 5, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

	On demand available after airing until May 5, 2021

Catalent, Consumer Healthcare Products Association (CHPA), The Nicholas Hall Group

Webcasts

Gain insight from Nicholas Hall, the Consumer Healthcare Products Association, and Catalent into the performance of the OTC market, some of the innovation trends and opportunities that are emerging, and the impact of OTC monograph reform on future developments.
Live: Tuesday, May 5, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after airing until May 5, 2021 
Register free


OTC Trends, Monograph Reform, and Innovation

Articles

Drug formulators are often tasked with trying to increase the bioavailability of poorly water-soluble drugs. This Pharmaceutical Technology eBook takes an in-depth look at one approach: Spray Drying for Bioavailability Enhancement.


Spray Drying for Bioavailability Enhancement

Accelerating Timeline by Planning for Clinical Supplies in Advance

	Scaling-up liquid formulations can present a number of challenges and headaches. This is especially true for complex solutions, suspensions and emulsions as well as biologics, sterile products, potent compounds and sensitive APIs. In this webcast, learn about potential formulation and filling issues when transitioning a liquid formulation from feasibility through commercialization.

	Product development experts share insights on a variety of formulation issues including mixing, solubility, microfluidization, viscosity, filtration and special API handling, with discussed solutions based on Catalent’s expertise in complex formulation. Equipment for liquid-filling and scale-up will be discussed with a focus on potential applications of advanced aseptic Blow-Fill-Seal (BFS) technology.

	Register early and submit your question for the Q&A discussion.

		How to manage challenges associated with typical liquid formulations, as well as unique issues for complex solutions, suspensions, and emulsions

		Special considerations for biologics, as well as potent or sensitive APIs

		Challenges when transitioning from small- to large-scale, and solutions made possible by Blow-Fill-Seal technology

Waiken Wong, PhD, Manager, Product Development Engineering, Catalent

	Wendy Khine, Director, Project Management, Catalent

Tuesday, Mar. 17, 2020 at 1pm EDT | 12pm CDT | 10am PDT

	On demand available after airing until Mar. 17, 2021

Complex liquids can be problematic for scale-up and manufacture.  Learn how the experts at Catalent have found solutions for the most challenging liquid formulations. 
Live: Tuesday, Mar. 17, 2020 at 1pm EDT | 12pm CDT | 10am PDT
On demand available after airing until Mar. 17, 2021 
Register free


Complex Liquid Formulations: Solutions for Scale-Up Challenges

http://www.pharmtech.com/pt_w/global_trials

	With an increasing number of clinical studies being conducted in the Asia-Pacific (APAC) region, there is a growing need for streamlining import and export strategies and clinical supply support. Multiple factors, including positive changes in clinical research regulations, reduced costs to run trials, and large urban-centered populations are attracting sponsors to the region.

	Singapore has long been a gateway into the region for sponsors, offering well-established regulations and an excellent infrastructure. The city can serve as an ideal hub for the import and export of clinical supplies into and throughout the APAC region.

	Register for this webcast to get expert insights on using Singapore as a clinical supply hub.

		The economic and regulatory advantages of using Singapore to supply global studies

		Overcoming challenges in running clinical trials in the APAC countries

		Singapore’s import and export capabilities to support the APAC region

		The importance of clinical supply management to optimize strategy and support timely execution of trials

		Customs influence on returns and destructions

Julie Delaney, Director, Clinical Supplies and Project Management, APAC, Catalent

	Rognvald Lamb, Director, Transportation Services, Clinical Supply Services, Catalent


	US & Europe Broadcast: Wednesday, Feb. 19, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET

	Asia-Pacific Broadcast: Thursday, Feb. 20, 2020 at 8:30am IST | 11am CST | 12pm JST

	On demand available after airing until Feb. 19, 2021

How can you overcome clinical import and export challenges within the Asia-Pacific region? Join Catalent’s Julie Delaney and Rognvald Lamb as they present the advantages of using Singapore as an APAC clinical supply hub. 
Live: US & Europe Broadcast: Wednesday, Feb. 19, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET 
Asia-Pacific Broadcast: Thursday, Feb. 20, 2020 at 8:30am IST | 11am CST | 12pm JST 
On demand available after airing until Feb. 19, 2021 
Register free
